On Friday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $23.42 which represents a slight increase of $0.18 or 0.77% from the prior close of $23.24. The stock opened at $23.

As the rising star of cell therapy biotechs, Iovance Biotherapeutics (NASDAQ: IOVA) is a hot stock that's capturing a lot of ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

President-elect Donald Trump announced on Nov. 21 that he had chosen Pam Bondi, a longtime supporter of his and Florida’s ...

Trump said in a statement on Nov. 22 that Dr. Nesheiwat has "an unwavering commitment to saving and treating thousands of ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...

Learn all about Hallmark's new movie, "Christmas on Call," including where it was filmed and the cast involved.

The School is aimed at a broad audience that includes students with a keen interest in complexity or bio-inspired ...

This week, Netflix's top 10 shows range from the world of the Karate Kid to sitcoms and family animation. Cobra Kai is ruling ...

Penn Engineers have cooked up a new way to improve mRNA delivery, developing an optimal “recipe” for ionizable lipids — key ...